Exact Mass: 511.2381
Exact Mass Matches: 511.2381
Found 268 metabolites which its exact mass value is equals to given mass value 511.2381
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cerebrocrast
Bis(2-propoxyethyl) 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylate
Ile His Asn Glu
Gln His Val Glu
Ile Asn His Glu
verruculogen
An organic heterohexacyclic compound that is a mycotoxic indole alkaloid isolated from Penicillium and Aspergillus species. CONFIDENCE Penicillium amphipolaria
Ala Phe Phe Gln
Ala Phe Gln Phe
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Met Tyr Lys
Ala Gln Phe Phe
Ala Tyr Lys Met
Ala Tyr Met Lys
Cys His Pro Arg
Cys His Arg Pro
Cys Lys Val Tyr
Cys Lys Tyr Val
Cys Pro His Arg
Cys Pro Arg His
Cys Arg His Pro
Cys Arg Pro His
Cys Val Lys Tyr
Cys Val Tyr Lys
Cys Tyr Lys Val
Cys Tyr Val Lys
Asp His Ile Gln
Asp His Leu Gln
Asp His Gln Ile
Asp His Gln Leu
Asp Ile His Gln
Asp Ile Gln His
Asp Leu His Gln
Asp Leu Gln His
Asp Gln His Ile
Asp Gln His Leu
Asp Gln Ile His
Asp Gln Leu His
Glu His Ile Asn
Glu His Leu Asn
Glu His Asn Ile
Glu His Asn Leu
Glu His Gln Val
Glu His Val Gln
Glu Ile His Asn
Glu Ile Asn His
Glu Leu His Asn
Glu Leu Asn His
Glu Asn His Ile
Glu Asn His Leu
Glu Asn Ile His
Glu Asn Leu His
Glu Gln His Val
Glu Gln Val His
Glu Val His Gln
Glu Val Gln His
Phe Ala Phe Gln
Phe Ala Gln Phe
Phe Phe Ala Gln
Phe Phe Gln Ala
Phe Lys Met Ser
Phe Lys Ser Met
Phe Met Lys Ser
Phe Met Ser Lys
Phe Gln Ala Phe
Phe Gln Phe Ala
Phe Ser Lys Met
Phe Ser Met Lys
His Cys Pro Arg
His Cys Arg Pro
His Asp Ile Gln
His Asp Leu Gln
His Asp Gln Ile
His Asp Gln Leu
His Glu Ile Asn
His Glu Leu Asn
His Glu Asn Ile
His Glu Asn Leu
His Glu Gln Val
His Glu Val Gln
His Ile Asp Gln
His Ile Glu Asn
His Ile Asn Glu
His Ile Gln Asp
His Leu Asp Gln
His Leu Glu Asn
His Leu Asn Glu
His Leu Gln Asp
His Asn Glu Ile
His Asn Glu Leu
His Asn Ile Glu
His Asn Leu Glu
His Pro Cys Arg
His Pro Arg Cys
His Gln Asp Ile
His Gln Asp Leu
His Gln Glu Val
His Gln Ile Asp
His Gln Leu Asp
His Gln Val Glu
His Arg Cys Pro
His Arg Pro Cys
His Val Glu Gln
His Val Gln Glu
Ile Asp His Gln
Ile Asp Gln His
Ile Glu His Asn
Ile Glu Asn His
Ile His Asp Gln
Ile His Glu Asn
Ile His Gln Asp
Ile Asn Glu His
Ile Gln Asp His
Ile Gln His Asp
Lys Ala Met Tyr
Lys Ala Tyr Met
Lys Cys Val Tyr
Lys Cys Tyr Val
Lys Phe Met Ser
Lys Phe Ser Met
Lys Met Ala Tyr
Lys Met Phe Ser
Lys Met Ser Phe
Lys Met Tyr Ala
Lys Ser Phe Met
Lys Ser Met Phe
Lys Val Cys Tyr
Lys Val Tyr Cys
Lys Tyr Ala Met
Lys Tyr Cys Val
Lys Tyr Met Ala
Lys Tyr Val Cys
Leu Asp His Gln
Leu Asp Gln His
Leu Glu His Asn
Leu Glu Asn His
Leu His Asp Gln
Leu His Glu Asn
Leu His Asn Glu
Leu His Gln Asp
Leu Asn Glu His
Leu Asn His Glu
Leu Gln Asp His
Leu Gln His Asp
Met Ala Lys Tyr
Met Ala Tyr Lys
Met Phe Lys Ser
Met Phe Ser Lys
Met Lys Ala Tyr
Met Lys Phe Ser
Met Lys Ser Phe
Met Lys Tyr Ala
Met Ser Phe Lys
Met Ser Lys Phe
Met Tyr Ala Lys
Met Tyr Lys Ala
Asn Glu His Ile
Asn Glu His Leu
Asn Glu Ile His
Asn Glu Leu His
Asn His Glu Ile
Asn His Glu Leu
Asn His Ile Glu
Asn His Leu Glu
Asn Ile Glu His
Asn Ile His Glu
Asn Leu Glu His
Asn Leu His Glu
Pro Cys His Arg
Pro Cys Arg His
Pro His Cys Arg
Pro His Arg Cys
Pro Arg Cys His
Pro Arg His Cys
Gln Ala Phe Phe
Gln Asp His Ile
Gln Asp His Leu
Gln Asp Ile His
Gln Asp Leu His
Gln Glu His Val
Gln Glu Val His
Gln Phe Ala Phe
Gln Phe Phe Ala
Gln His Asp Ile
Gln His Asp Leu
Gln His Glu Val
Gln His Ile Asp
Gln His Leu Asp
Gln Ile Asp His
Gln Ile His Asp
Gln Leu Asp His
Gln Leu His Asp
Gln Val Glu His
Gln Val His Glu
Arg Cys His Pro
Arg Cys Pro His
Arg His Cys Pro
Arg His Pro Cys
Arg Pro Cys His
Arg Pro His Cys
Arg Ser Ser Tyr
Arg Ser Tyr Ser
Arg Tyr Ser Ser
Ser Phe Lys Met
Ser Phe Met Lys
Ser Lys Phe Met
Ser Lys Met Phe
Ser Met Phe Lys
Ser Met Lys Phe
Ser Arg Ser Tyr
Ser Arg Tyr Ser
Ser Ser Arg Tyr
Ser Ser Tyr Arg
Ser Tyr Arg Ser
Ser Tyr Ser Arg
Val Cys Lys Tyr
Val Cys Tyr Lys
Val Glu His Gln
Val Glu Gln His
Val His Glu Gln
Val His Gln Glu
Val Lys Cys Tyr
Val Lys Tyr Cys
Val Gln Glu His
Val Gln His Glu
Val Tyr Cys Lys
Val Tyr Lys Cys
Tyr Ala Lys Met
Tyr Ala Met Lys
Tyr Cys Lys Val
Tyr Cys Val Lys
Tyr Lys Ala Met
Tyr Lys Cys Val
Tyr Lys Met Ala
Tyr Lys Val Cys
Tyr Met Ala Lys
Tyr Met Lys Ala
Tyr Arg Ser Ser
Tyr Ser Arg Ser
Tyr Ser Ser Arg
Tyr Val Cys Lys
Tyr Val Lys Cys
Litronesib
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(1S)-2-oxobornane-10-sulphonic acid, compound with 7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
1,3,5-Triazine, 2,4-diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1-biphenyl]-3-yl]-
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].